All Types of Alcohol Linked to Breast Cancer Risk

A recent study by Kaiser Permanente Researchers has found that the effects of alcohol on breast cancer are the same, regardless of whether a woman drinks wine, beer, or liquor. The ethyl alcohol found in those drinks and the quantity consumed are the factors that weigh heavily on breast cancer risk. Researchers believe the increased risk from three or more drinks a day is similar to the increased breast cancer risk from smoking a pack of cigarettes a day or more. They claim that "Population studies have consistently linked drinking alcohol to an increased risk of female breast cancer, but until now there has been little data, most of it conflicting, about an independant role played by the choice of beverage type."

The team of Kaiser Permanente researchers studied the drinking habits of over 70,000 women of varying ethnicities who had supplied information during health exams between 1978 and 1985. By the year 2004, 2,800 of these women were diagnosed with breast cancer. Researchers analyzed three aspects of the records; they compared alcohol intake among women who favored specific beverages, the frequency of drinking each beverage type, and the role of total alcoholic intake compared with women who drank less than one drink a day.

The results found no difference among the varying types of alcoholic beverages, even when wine was divided into red and white. Researchers found the risk of breast cancer rose by 30 percent in women who drank more than three drinks a day. They claim that "We think that the heart protection benefit from alcohol is real, and is probably derived largely from alcohol-induced higher HDL or "good" cholesterol, reduced blood clotting and reduced diabetes." However, they warn "Our findings provide more evidence for why heavy drinkers should quit or cut down."

What Women Know About Breast Cancer Treatment Options

Women in the US have around a 1 in 8 chance of developing breast cancer at some stage in their lives, and a three percent chance of dying from it. Breast cancer is the leading cause of cancer death among women the world over, and is second only to heart disease in total numbers of deaths caused.

Treatment of breast cancer is an extremely important issue - yet many women do not know their treatment options for breast cancer. What do most women know about treating breast cancer, and what can cancer hospitals do to help women make better informed choices?

Breast cancer is the second most common cancer worldwide, the leading cancer in women, and the second leading cause of death in women worldwide. It has an incidence rate more than twice that of cervical cancer and colorectal cancer, and three times as high as lung cancer in women. It follows that breast cancer is one of the most researched and publicized conditions - however, many groups in our society know little about their treatment options for breast cancer.

Recent research has revealed that nearly half of women being treated for breast cancer did not know that their odds of survival were just as good whether they underwent a complete mastectomy, or breast conserving surgery. One of the greatest impacts of breast cancer on its survivors is on their mental health and self-image. The loss of a breast can have a huge impact on how a woman feels about herself, which in turn affects her general health and the attention she pays to her body.

The study was carried out by The University of Michigan Comprehensive Cancer Center. It discovered that many women do not understand the differences between treatment options for breast cancer, and minority women are even less likely to be aware of the impact their decisions will have on their prognosis. This was found to be true even though surgeons communicated the differences to their patients in all cases - the information simply didn't seem to be integrated into the decision making process.

One factor that the researchers note is that information about breast cancer treatment must be communicated in a culturally appropriate and sensitive way. With medical tourism and overseas treatment now creating a large part of the cancer-treatment demographic, this clear communication is more important than ever.

Hospitals which focus on medical tourism, like Bangkok Hospital in Thailand, as well as Bumrungrad in Thailand, understand the importance of cultural sensitivity when communicating with patients. Bangkok Hospital, for example, takes a range of steps to make sure that overseas patients feel as 'at-home' as possible while in the hospital, with different dietary options, doctor that speak several languages, as well as translators for all the languages not spoken by the doctors themselves, and signage and information provided in several languages.

In many cases, patients may find that doctors in Thai hospitals for breast cancer like Bangkok Hospital and Bumrungrad have their treatment options more clearly communicated to them than they would in the West. Both of these cancer treatment hospitals in Thailand have specialized breast care clinics, focusing on early detection and diagnosis, as well as treatment of breast cancer in Thailand.

Given the more international, diverse focus of Thailand's breast cancer hospitals, treatment as a medical tourist may make more sense, and provide better outcomes for women with breast cancer.

* This article also published on ezinearticles.com

Concerning Breast Cancer with Research and Treatment

Breast cancer is considered as a killer disease and it is known to be the top cause of cancer death among women. According to American cancer society, about 1.3 million new breast cancer cases are diagnosed on an annually basis which includes 465,000 deaths. In order to successfully tackle this devastating disease, we must encourage innovative scientists to study cancer at its most basic level. In other words, breast cancer research work should be conducted at its molecular level. Also, besides the governments, private organizations should provide flexible funding to scientists who will be conducting breast cancer research work. Proper funding of breast cancer research projects; can not only lead to better prevention strategies but it can also help towards earlier diagnostic techniques and new anticancer drugs and treatments.

A world renowned cancer researcher, named Lothar Hirneise has come to an understanding that cancer exist with stress. He is of the opinion that when the mind is under constant stress, the body then produces high levels of stress hormone called Cortisol. The immune system gets suppressed with high levels of Cortisol in the body. Also, a stressed mind will release out Adrenaline to an extent of depletion. People suffering from cancer are found to be having almost no adrenaline in their cells. In fact, cells of cancer patient are often overloaded with insulin and plenty of sugar. Another leading German cancer researcher by the name of ‘Ryke-Geerd Hamer has gone through twenty thousand cancer patients and found a direct relationship between psycho-emotional conflict and cancer patients. This occurs between 1 to 3 years, prior to cancer diagnosis and cancer forming within the body. Cancer patients, who have experienced a psycho – emotional conflict shock, in the form of loss of a loved one etc, few years prior to their cancer urine, has experienced emotional pain and stress within themselves. Such a state of mind can have an adverse effect on the immune system of the person’s body.

Recently, researchers who are working towards breast cancer research project, have developed and successfully tested a breast cancer vaccine which is likely to treat women with treatment – resistant HER2 – positive breast cancer and thus be able to prevent cancer re – occurrence. Breast cancer researchers look forward to use HER2 DNA vaccines for cancer – free women, in order to prevent initial development of such tumours. At present, therapies such as trastuzumab and lapatimib are used towards treating breast cancer patients. However, it was lately noticed that a huge group of patients develop a resistance towards trastuzumab and lapatimib. HER2 receptors are known to promote a particularly aggressive type of tumour that affects about thirty percent of breast cancer patients.

The new breast cancer vaccine is produced by the body’s own cells. It delivers a cancer fighting gene into cells, which then produce immune system proteins and also tumor – destroying cells. According to the lead researcher Wei – Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is made by using so – called naked DNA from genes that produces the HER2 receptor. This DNA is put along with an immune stimulant. The process involved in the making of the vaccine, is called as electroporation. In this process, pulses of electricity were used in order to inject the vaccine into the leg muscles in mice. The genes moved towards the cells, which then produced HER2 receptors that led to activation of antibodies and immune cells called Killer T cells. This vaccine is unique and much more research will be further required so that it can one day be applicable towards humans for treating breast cancer.

Breast Cancer

Breast cancer is a malignant (cancerous) growth that begins in the tissues of the breast. Cancer is a disease in which abnormal cells grow in an uncontrolled way. Breast cancer is the most common cancer in women, but it can also appear in men. In the U.S., it affects one in eight women.